Rifaximin for active ulcerative colitis.
Guslandi
Mario
M
Petrone
Maria Chiara
MC
Testoni
Pier Alberto
PA
D000328:Adult; D000368:Aged; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012294:Rifamycins / Q000008:administration & dosage / Q000627:therapeutic use*; D000078262:Rifaximin; D016896:Treatment Outcome
D005765:Gastrointestinal Agents; D012294:Rifamycins; D000078262:Rifaximin